Clinical trial

CKD-330 Phase 3 Trial in Amlodipine Non-responder

NCT02586311

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-01-01

PhasePHASE3

Study timeline

Study start (unknown)2016-01-01Date precision: month

Registry last updated2016-10-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertensionunresolved

Interventions

CKD-330 16/5mgDRUG

Amlodipine 5mg PlaceboDRUG

CKD-330 16/5mg PlaceboDRUG

Amlodipine 5mgDRUG

Sponsors & collaborators

Chong Kun Dang Pharmaceuticallead sponsor

Mapped research locations

SeoulSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02586311 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.